Stefan Lindgren
121 – 125 of 141
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
High sustained response rate in patients with histologically mild (low grade and stage) chronic hepatitis C infection. A randomized, double blind, placebo controlled trial of interferon alpha-2b with and without ribavirin.
(
- Contribution to journal › Article
-
Mark
Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy
(
- Contribution to journal › Article
-
Mark
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
(
- Contribution to journal › Article
-
Mark
Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
(
- Contribution to journal › Article
- 2001
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
(
- Contribution to journal › Article